Public Health Update
  • Home
  • Public Health Update
  • Nepal Health Jobs
    • Public Health Job Board
    • Organization List
  • Opportunities
    • Fellowships, Studentship & Scholarships
    • Grants and Funding Opportunities
    • Fully funded
    • Conference
  • Downloads
    • International Plan, Policy & Guidelines
    • National Plan, Policy & Guidelines
    • Reports
    • Public Health Notes
    • Syllabus
    • Form Formats
  • School of Public Health
    • PhD
    • Master’s Degree
    • Online Courses
  • Notice
  • Home
  • Public Health Update
  • Nepal Health Jobs
    • Public Health Job Board
    • Organization List
  • Opportunities
    • Fellowships, Studentship & Scholarships
    • Grants and Funding Opportunities
    • Fully funded
    • Conference
  • Downloads
    • International Plan, Policy & Guidelines
    • National Plan, Policy & Guidelines
    • Reports
    • Public Health Notes
    • Syllabus
    • Form Formats
  • School of Public Health
    • PhD
    • Master’s Degree
    • Online Courses
  • Notice
LOGIN / REGISTER
Public Health Update
SUBSCRIBE
Public Health Update
Public Health Update
  • Home
  • Public Health Update
  • Nepal Health Jobs
    • Public Health Job Board
    • Organization List
  • Opportunities
    • Fellowships, Studentship & Scholarships
    • Grants and Funding Opportunities
    • Fully funded
    • Conference
  • Downloads
    • International Plan, Policy & Guidelines
    • National Plan, Policy & Guidelines
    • Reports
    • Public Health Notes
    • Syllabus
    • Form Formats
  • School of Public Health
    • PhD
    • Master’s Degree
    • Online Courses
  • Notice

All Right Reserved. Designed and Developed by PenciDesign

The State of Food Security and Nutrition in the World 2023
Fact SheetGlobal Health NewsHealth in DataLife Style & Public Health NutritionPublic HealthPublic Health Update

The State of Food Security and Nutrition in the World 2023

by Public Health Update July 14, 2023
written by Public Health Update

The State of Food Security and Nutrition in the World is an annual report jointly prepared by the Food and Agriculture Organization of the United Nations (FAO), the International Fund for Agricultural Development (IFAD), the United Nations Children’s Fund (UNICEF), the World Food Programme (WFP) and the World Health Organization (WHO).

The State of Food Security and Nutrition in the World 2023, launched on 12 July 2023, provides a comprehensive overview of these complexities. The 2023 edition of the report reveals that between 691 and 783 million people faced hunger in 2022, with a mid-range of 735 million. This represents an increase of 122 million people compared to 2019, before the COVID-19 pandemic. 

While global hunger numbers have stalled between 2021 and 2022, there are many places in the world facing deepening food crises. Progress in hunger reduction was observed in Asia and Latin America, but hunger was still on the rise in Western Asia, the Caribbean and throughout all subregions of Africa in 2022. Africa remains the worst-affected region with one in five people facing hunger on the continent, more than twice the global average.

Key messages

  • Global hunger, measured by the prevalence of undernourishment (Sustainable Development Goal [SDG] Indicator 2.1.1), remained relatively unchanged from 2021 to 2022 but is still far above pre-COVID-19-pandemic levels, affecting around 9.2 percent of the world population in 2022 compared with 7.9 percent in 2019.
  • It is estimated that between 691 and 783 million people in the world faced hunger in 2022. Considering the midrange (about 735 million), 122 million more people faced hunger in 2022 than in 2019, before the global pandemic.
  • From 2021 to 2022, progress was made towards reducing hunger in Asia and in Latin America, but hunger is still on the rise in Western Asia, the Caribbean and all subregions of Africa.
  • It is projected that almost 600 million people will be chronically undernourished in 2030. This is about 119 million more than in a scenario in which neither the pandemic nor the war in Ukraine had occurred, and around 23 million more than if the war in Ukraine had not happened. This points to the immense challenge of achieving the SDG target to eradicate hunger, particularly in Africa.
  • The prevalence of moderate or severe food insecurity at the global level (SDG Indicator 2.1.2) remained unchanged for the second year in a row after increasing sharply from 2019 to 2020. About 29.6 percent of the global population – 2.4 billion people – were moderately or severely food insecure in 2022, of which about 900 million (11.3 percent of people in the world) were severely food insecure.
  • Worldwide, food insecurity disproportionately affects women and people living in rural areas. Moderate or severe food insecurity affected 33.3 percent of adults living in rural areas in 2022 compared with 28.8 percent in peri-urban areas and 26.0 percent in urban areas. The gender gap in food insecurity at the global level, which had widened in the wake of the pandemic, narrowed from 3.8 percentage points in 2021 to 2.4 percentage points in 2022.
  • More than 3.1 billion people in the world – or 42 percent – were unable to afford a healthy diet in 2021. While this represents an overall increase of 134 million people compared to 2019, before the pandemic, the number of people unable to afford a healthy diet actually fell by 52 million people from 2020 to 2021.
  • Worldwide in 2022, an estimated 148.1 million children under five years of age (22.3 percent) were stunted, 45 million (6.8 percent) were wasted, and 37 million (5.6 percent) were overweight. The prevalence of stunting and wasting was higher in rural areas, while overweight was slightly more prevalent in urban areas.
  • Steady progress has been made on increasing exclusive breastfeeding for the first six months of life and reducing stunting among children under five years of age, but the world is still not on track to achieve the 2030 targets. Child overweight and low birthweight have changed little, and the prevalence of wasting is more than double the 2030 target.
  • Increasing urbanization, with almost seven in ten people projected to live in cities by 2050, is driving changes in agrifood systems across the rural–urban continuum. These changes represent both challenges and opportunities to ensure everyone has access to affordable healthy diets.
  • Challenges include a greater availability of cheaper, convenience, pre-prepared and fast foods, often energy dense and high in fats, sugars and/or salt that can contribute to malnutrition; insufficient availability of vegetables and fruits to meet the daily requirements of healthy diets for everyone; exclusion of small farmers from formal value chains; and loss of lands and natural capital due to urban expansion.
  • But urbanization also presents opportunities, as it results in longer, more formal and complex food value chains that expand income-generating activities in off-farm employment, especially for women and youth, and increase the variety of nutritious foods. Farmers often gain better access to agricultural inputs and services as urban areas grow closer to rural areas.
  • Understanding the changes occurring throughout agrifood systems (i.e. from food production, food processing, and food distribution and procurement, to consumer behaviour) requires a rural–urban continuum lens, reflecting the growing connectivity and interlinkages across urban, peri-urban and rural areas.
  • While already quite advanced in Asia and Latin America, changes in food demand and supply across the rural–urban continuum are accelerating in Africa, where the shares of the population that are food insecure and unable to afford a healthy diet are among the highest in the world. Here the expansive growth in off-farm employment and interconnected food markets and food supply chains is driving a diet transition across the rural–urban continuum.
  • New evidence for 11 Western, Eastern and Southern African countries challenges the traditional thinking that food purchases make up a small share of rural households’ food consumption in Africa. Food purchases are high among urban households in these countries, but they are also surprisingly high across the rural–urban continuum, even among rural households living far from an urban centre.
  • New evidence also challenges the conventional thinking that purchase patterns between urban and rural areas differ markedly. In the 11 African countries studied, although consumption of processed foods, including highly processed foods, is higher in urban areas, it only declines gradually moving to peri-urban and rural areas. Moreover, consumption of vegetables, fruits, and fats and oils is fairly uniform across the rural–urban continuum relative to total food consumption.
  • The affordability of a healthy diet is becoming more critical to households living in peri-urban and rural areas because they rely more on food purchases. In the 11 African countries studied, despite the lower cost of a healthy diet in these areas, affordability is still lower than in urban centres. Low-income households living in peri-urban and rural areas are especially disadvantaged, as they would need to more than double their food expenditure to secure a healthy diet.
  • In many of these African countries studied, food security is not exclusively a rural problem, as moderate or severe food insecurity across urban areas (large, intermediate and small cities and towns) and peri-urban areas (less than 1 hour travel to large, intermediate and small cities) is similar to and sometimes even slightly higher than in rural areas.
  • The prevalence of child overweight is at risk of increasing with the emerging problem of high consumption of highly processed foods and food away from home in urban centres, which is increasingly spreading into peri-urban and rural areas.
  • Increasing access to affordable healthy diets and achieving food security and nutrition for all require a policy approach and legislation that leverage the increasing connectivity between rural and peri-urban areas and cities of various sizes.
  • The closer linkages among agrifood systems segments create opportunities for win–win situations in terms of greater economic development and access to affordable healthy diets, which can be seized through investments in infrastructure, public goods and enhanced capacities that improve rural–urban connectivity. Such investments should support the essential role of small and medium enterprises in agrifood systems, particularly in small and intermediate cities and towns.
  • Public investment in research and development needs to be increased to develop technologies and innovations for healthier food environments and for increasing the availability and affordability of nutritious foods. Technology can be particularly important to boost the capacity of urban and peri-urban agriculture to supply nutritious foods in cities and towns.
  • Leveraging connectivity across the rural–urban continuum will require adequate governance mechanisms and institutions to coordinate coherent investment beyond sectoral and administrative boundaries. To this end, subnational governments can play a key role in designing and implementing policies beyond the traditional top-down approach. Approaches to agrifood systems governance should ensure policy coherence among local, regional and national settings through the engagement of relevant agrifood systems stakeholders at all levels.

Screen Shot 2023 07 14 at 08.00.39
Global Hunger Status
Screen Shot 2023 07 14 at 08.03.10
Nepal

Report: full digital report

Report the In Brief



Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

  • World Water Day 2026 | Water & Gender Equality
  • Nepal Antimicrobial Resistance (AMR) Bulletin FY 2081/82
  • Call for applications! Short Course on Qualitative Research Methods in Public Health, 2026
  • World Obesity Day 2026 | 8 Billion Reasons to Act on Obesity
  • Salim Yusuf Emerging Leaders Programme 2026

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated



  • WordPress
  • Link
  • Facebook
  • Mail
  • Facebook
  • Twitter
  • Twitter
  • LinkedIn
  • Instagram
  • Facebook
July 14, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
ConferencePublic Health OpportunitiesPublic Health Opportunity

National Nursing Conference for Nursing Scholars 2023

by Public Health Update July 5, 2023
written by Public Health Update

Patan Academy of Health Sciences, School of Nursing and Midwifery (Lalitpur Nursing Campus) is organizing “The First National Nursing Conference for Nursing Scholars, 2023” with the theme of Leading Together for the Prevention and Control of Non-communicable Diseases, and Mental Health Problems: Advancing Nursing Sciences.” This is the first national nursing conference targeting to stimulate Nursing graduates, current students, nursing educators, nurse researcher, nurse educators, nurse administrators, nurses, and other health professionals to present their research work which will facilitate to broaden the knowledge of participants in nursing profession. This conference further aims to exchange experiences among participants and strengthen a network among them.

Important Activities related to ConferenceImportant Dates
Conference Date8 & 9 Asoj 2080 (25 & 26 September 2023)
Abstract Call1 February 2023 (18 Magh 2079) onwards
Registration1 February 2023 (18 Magh 2079) onwards
Early Bird Registration1 February 2023 (18 Magh 2079) to 13 September 2023 (27 Bhadra 2080)]Early Bird Registration Fee:NRs. 3000For Students: NRs. 2000
Late Registration14 September 2023 Onward (28 Bhadra 2080)]Registration Fee: NRs.3500,For Students: NRs. 2500
Abstract Submission Deadlines:25 July 2023 (9 Shrawan 2080)
Notification of Acceptance of Abstract:15 August 2023 (30 Shrawan 2080)
VenueHeritage Garden, Sanepa, Lalitpur-2In front of Patan Academy of Health Science, School of Nursing and Midwifery, (Lalitpur Nursing Campus)

Expected Attendees

This First National Nursing Conference for Nursing Scholars, 2023 is open to all nursing graduates, current students, nursing educators, nurse researchers, nurse educators, nurse administrators, nurses, as well as who are interested in sharing and learning together in nursing. Thus, we are very pleased to invite all interested people/organizations to kindly prepare and submit abstract under the themes mentioned below.

Objectives

After attending this conference, the participants will be able to:

  • gain relevant perspectives on leading together the prevention and control of non-communicable diseases, and mental health problems through advancing nursing sciences
  • discuss the activities for the advancement of nursing practices for the prevention, control, and management of NCDs through research and innovation
  • share and promote evidence-based findings on the latest trends and health issues related to NCDs and mental health problems in nursing practice, education, research, administration and policy for the prevention, promotion, rehabilitation and care of people living with NCDs.

This is an announcement for submission of an abstract for the Conference on First National Nursing Conference for Nursing Scholars, 2023, with the theme of “Leading Together for the Prevention and Control of Non-communicable Diseases, and Mental Health Problems: Advancing Nursing Sciences” that is being organized in Kathmandu, Nepal from 8-9 ASOJ 2080 (25 & 26 September 2023). The presentation under the following themes will be arranged through parallel or plenary session.

Theme of conference

Abstracts are accepted focusing on non-communicable diseases and mental health problems are accepted but are not limited to the following specialty.

  • Medical-Surgical Nursing
  • Community Nursing
  • Mental Health and Psychiatric Nursing
  • Child and Adolescent Health Nursing
  • Maternal Health Nursing
  • Disasters and Emergency Nursing
  • Critical Care Nursing
  • Geriatric Nursing and Palliative Care
  • Nursing Innovation
  • Nursing Administration & Management

Abstract Submission Guidelines

  1. Provide full title on abstract page. The title should be short and concise and should be in title case
  2. All submissions will be acknowledged by email. So, please provide email address of corresponding author along with Mobile number. Authorship information should carry in sequence information on primary author and other authors with their position, affiliated institution and highest academic qualification.
  3. The text of the abstract should not exceed 300 words (in Times New Roman, Font Size 12pts). Total word count does not include keywords
  4. Abstracts should be submitted in English.
  5. The abstract should be ‘structured’ as:

Background/contexts: General introduction and the study objectives, the hypothesis tested, or a thorough description of the problem/issue;

Methods/approach: Study design, materials and methods used to collect data/information, type of analysis used, statistical analysis used (if any), approach and intervention for implementation, etc.

Results: Specific results, discussion,

Conclusion(s) and recommendation:

Keywords: Below the abstract, it is essential to provide 3-5 keywords arranged alphabetically, separated by a comma, all small cases.

  1. Do not include references in the abstract.
  2. Avoid the use of abbreviations unless necessary (e.g., to avoid repetition of long words/phrases that may affect word counts). If it is necessary to use abbreviations, you should mention the full words followed by abbreviations in brackets for the first time, then you can use abbreviations in subsequent writing.
  3. By submission of an abstract, the author transfers copyright ownership to the organizing committee for publications. The organizing committee reserves the right to reproduce the abstract / presentation made in conference in print or electronic media if your abstract is accepted.
  4. The abstract should be free of grammatical errors and spelling mistakes.

Note: Abstract which has been accepted for the conference will be further evaluated for the conference proceedings. If the abstract is selected for the proceedings, full article will be requested to the authors.

  1. Abstracts should be sent by email to Conference Secretariat, Lalitpur in following address: sonm_conference@pahs.edu.np
  2. The deadline for abstract submission is 25 July 2023 (9 Shrawan 2080).
  3. This guideline and abstract form will be available at www.pahs.edu.np. You can mention the form of presentation as oral or written in the abstract.
  4. An independent Scientific Committee panel formed for the conference will review the abstracts for selection. The authors will have an option to choose a method of presentation i.e., either poster or oral at the time of abstract submission. However, the committee reserves all rights to assign any accepted abstract for oral or poster presentation. The committee also reserves the right for rejection of any submitted abstract.
  5. Notification of acceptance will be sent to the corresponding author by 15 August 2023 (30 Shrawan 2080) by email.
  6. If you have any queries, please feel free to correspond to sonm-conference@pahs.edu.np

Contact: Pravas Pokharel, Email ID: sonm_conference@pahs.edu.np, Contact No: 9851168105

READ MORE AND REGISTER NOW
July 5, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Public Health Opportunity! Explore world's trending global health opportunities! Visit us for latest public health opportunities.
Call for Proposal, EOI & RFPInternational Jobs & OpportunitiesOpportunities by RegionPublic Health OpportunitiesPublic Health OpportunityVector-Borne Diseases(VBDs)

Call for experts for the Vector Control Advisory Group (VCAG)

by Public Health Update July 1, 2023
written by Public Health Update

The World Health Organization (WHO) is seeking experts to serve as members one of the Vector Control Advisory Group (VCAG). This “call for experts” provides information about the advisory group in question, the expert profiles being sought, the process to express interest, and the process of selection.

Background

Independent evaluation of the public health value of new interventions for vector control is needed to enable WHO to develop evidence-based recommendations aimed at informing the development of vector-borne disease control strategies by WHO Member States. These recommendations, published in WHO guidelines, are essential to ensure the optimal use of scarce resources available for vector-borne disease control.

In order to assist WHO guidelines development groups in developing recommendations on new interventions for vector control, VCAG provides guidance to manufacturers and researchers on developing the evidence base required to inform assessment of public health value, and provides an assessment of the evidence-base once it has been generated. Based on the VCAG assessment, WHO will then consider initiating the guidelines development process to support formulation of a recommendation, if warranted.

VCAG is jointly managed by the Global Malaria Programme, the Department of Control of Neglected Tropical Diseases, and the WHO Prequalification Team for Vector Control Products.

Functions of the Vector Control Advisory Group

The VCAG has the following specific functions:

  • To support WHO in providing guidance to applicants, via the WHO VCAG secretariat, on study designs for the generation of epidemiological data, intended to allow assessment of the public health value of new vector control interventions.
  • To support WHO in the evaluation the public health value of new vector control intervention classes, based on epidemiological studies submitted to WHO.
  • To advise WHO (i.e.: the relevant technical departments) on whether public health value has been demonstrated for a new vector control intervention.

→ See the full Terms of Reference for the Advisory group.

Operations of the Vector Control Advisory Group

VCAG members will be expected to meet, and to actively participate in convenings two times per year to meet with applicants, provide feedback on submissions and evaluate whether interventions under formal evaluation by WHO provide public health value against the targeted diseases. Meetings may be held in-person (in Geneva, Switzerland) or virtually, and usually run for three to four days (depending on the number of submissions to be reviewed and on whether the meeting is held virtually or in person).

VCAG members are required to review submissions in advance of the meetings, as well as contribute to drafting the meeting report, which constitutes the formal advice from the advisory group to WHO and provides a public record of each assessment.

Teleconferences in preparation of meetings or to support off-cycle reviews may be required and VCAG members are expected to participate in these. The working language of the group will be English.

Who can express interest?

VCAG is a multidisciplinary team, with members having a broad range of technical knowledge, skills and experience relevant to the evaluation of novel vector control interventions.

WHO welcomes expressions of interest from relevant technical experts (e.g. scientists, programme managers, regulators) involved in vector control and vector borne disease management, with expertise in the following areas:

  • Epidemiology
  • Study design and statistics
  • Vector biology and medical entomology
  • Vector ecology and population biology
  • Molecular biology/genetics and genetic modification of vectors
  • Pesticide products and insecticide resistance
  • Product development and regulation
  • Evaluation of public health products

Individuals from member states of EMRO, SEARO and WPRO, women, and those with expertise in Epidemiology, study design and statistics, are particularly encouraged to submit an application.

VCAG has ongoing member rotation, with members nominated following an open call. It is anticipated that between two to five new members will be selected annually to become members of the group, allowing a phased transition of the group membership. Selection of members following the call is outlined in the VCAG TOR.

Submitting your application

There are two components to the submission. To register your interest in being considered for the Vector Control Advisory Group, please:

  • Complete and submit this form online
  • submit your CV to vcag@who.int.

Both the form and your CV should be received before 21 July 2023, 23:59pm CEST (UTC+2). Incomplete applications (those that do not comprise the two components) will not be considered.

Within the form, you will be asked for:

  • Personal details (e.g. your name, contact details nationality and gender)
  • Your professional experience (e.g. areas of expertise and the vector-borne diseases with which you have experience)
  • Your motivation to apply for the advisory group. There is a limit of 4000 characters for this response; it is recommended that you prepare your motivation in advance, as the form cannot be saved once begun.

Your CV should be sent at the same time as you submit the form, with the email subject heading:
“VCAG – application to open call – [your surname]”.

After submission, your expression of interest will be reviewed by WHO. Due to an expected high volume of interest, only selected individuals will be contacted, and will then be requested to submit a Declaration of Interest form.

Data collected in this form will be used for the purpose of reviewing and shortlisting potential candidates for advisors to Vector Control Advisory Group. Data will not be shared with those external to WHO.

Important information about the selection processes and conditions of appointment

Members of WHO advisory groups must be free of any real, potential or apparent conflicts of interest. To this end, applicants are required to complete the WHO Declaration of Interests for WHO Experts, and the selection as a member of an advisory group is, amongst other things, dependent on WHO determining that there is no conflict of interest or that any identified conflicts could be appropriately managed (in addition to WHO’s evaluation of an applicant’s experience, expertise and motivation and other criteria).

All advisory group members will serve in their individual expert capacity and shall not represent any governments, any commercial industries or entities, any research, academic or civil society organizations, or any other bodies, entities, institutions or organizations. They are expected to fully comply with the Code of Conduct for WHO Experts (https://www.who.int/about/ethics/declarations-of-interest). Advisory group members will be expected to sign and return a completed confidentiality undertaking, and their declaration of interests prior to the beginning of the first meeting, and future meetings thereafter.

The selection of members of the advisory groups will be made by WHO in its sole discretion, taking into account the following (non-exclusive) criteria: relevant technical expertise; experience in international and country policy work; communication skills; and ability to work constructively with people from different cultural backgrounds and orientations. The selection of advisory group members will also take account of the need for diverse perspectives from different regions, especially from low and middle-income countries, and for gender balance.

At any point during the selection process, telephone interviews may be scheduled between an applicant and the WHO VCAG Secretariat to enable WHO to ask questions relating to the applicant’s experience and expertise and/or to assess whether the applicant meets the criteria for membership in the relevant AG.

If selected by WHO, proposed members will be sent an invitation letter and a Memorandum of Agreement. Appointment as a member of an advisory group will be subject to the proposed member returning to WHO the countersigned copy of these two documents.

WHO reserves the right to accept or reject any expression of interest, to annul the open call process and reject all expressions of interest at any time without incurring any liability to the affected applicant or applicants and without any obligation to inform the affected applicant or applicants of the grounds for WHO’s action. WHO may also decide, at any time, not to proceed with the establishment of the advisory group, disband an existing technical advisory group or modify the work of the advisory group.

WHO shall not in any way be obliged to reveal, or discuss with any applicant, how an expression of interest was assessed, or to provide any other information relating to the evaluation/selection process or to state the reasons for not choosing a member.

WHO will publish the names and a short biography of the VCAG members on the WHO VCAG website.

Advisory group members will not be remunerated for their services in relation to the advisory group or otherwise. Travel and accommodation expenses of advisory group members to participate in face-to-face advisory group meetings will be covered by WHO in accordance with its applicable policies, rules and procedures.

Appointment to the advisory group will be limited in time; the membership term for the group is three years, with the possibility of renewal for a second term, upon decision of the Secretariat.

If you have any questions about this call for experts, please write to vcag@who.int well before the applicable deadline, indicating in the subject line “VCAG call for experts – enquiry”.

July 1, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Public Health Opportunity! Explore world's trending global health opportunities! Visit us for latest public health opportunities.
Call for Proposal, EOI & RFPInternational Jobs & OpportunitiesNon- Communicable Diseases (NCDs)Public Health OpportunitiesPublic Health Opportunity

Call for Experts: Strategic and Technical Advisory Group on the Prevention and Control of NCDs

by Public Health Update July 1, 2023
written by Public Health Update

The World Health Organization (WHO) is seeking experts to serve as members of the Strategic and Technical Advisory Group on the Prevention and Control of Noncommunicable Diseases (NCDs). This “Call for experts” provides information about the advisory group in question, the expert profiles being sought, the process to express interest, and the process of selection.

Background

The Strategic and Technical Advisory Group on the Prevention and Control of Noncommunicable Diseases (STAG-NCD) was established in October 2021 to act as an advisory body to WHO to further WHO’s leadership and coordination role in promoting and monitoring global action against noncommunicable diseases.

The aim is to strengthen international and national action in these important public health areas and, thereby, (1) reduce premature mortality from NCDs through prevention and treatment [1] and (2) progressively cover additional people with health services, medicines, vaccines, diagnostics and health technologies [2] and (3) and strengthen efforts to address NCDs as part of UHC [3] and (4) provide guidance on priority activities and pathways to accelerate progress towards achievement of SDG target 3.4 through 2023–2030 [4].

[1] In accordance with SDG targets 3.4 (NCDs and its risk factors), 3.5 (harmful use of alcohol), 3.8 (UHC) and 3.a (tobacco control) of the 2030 Agenda for Sustainable Development
[2] In accordance with paragraph 24(a) of A/RES/74/2
[3] In accordance with paragraph 33 of A/RES/74/2
[4] In accordance with A/RES/75/10 

Functions of the Strategic and Technical Advisory Group on the Prevention and Control of Noncommunicable Diseases

In its capacity as an advisory body to WHO, the STAG-NCD has the following functions:

  • to identify and describe current and future challenges;
  • to advise WHO on strategic directions to be prioritized;
  • to advise WHO on the development of global strategic documents; and
  • to propose other strategic interventions and activities for implementation by WHO.

Operations of the Strategic and Technical Advisory Group on the Prevention and Control of Noncommunicable Diseases

The STAG-NCD normally meets twice per year. However, WHO may convene additional meetings. Meetings may be held in person (at WHO headquarters in Geneva or another location, as determined by WHO) or virtually, via video or teleconference.

STAG-NCD members are expected to attend meetings. If a member misses 2 consecutive meetings, WHO may end his/her appointment as a member of the STAG-NCD.

Active participation is expected from all STAG-NCD members, including in teleconferences, and interaction over email. Members may, in advance of meetings, be requested to review meeting documentation and to provide their views for consideration by the STAG-NCD.

The STAG-NCD meetings will be conducted in English. All documentation, including reports and working documents, will be provided in English.

Who can express interest?

The STAG-NCD is multidisciplinary, with members who have a range of technical knowledge, skills and experience relevant to the important areas mentioned below. Up to 24 members may be selected.

WHO welcomes expressions of interest from:

Scientists, public health experts, health care professionals, entrepreneurs, innovators and policy-makers representing the broad range of disciplines relevant to prevention of NCDs including, but not limited to: cardiovascular diseases, cancer, diabetes, chronic respiratory diseases, risk factors and social determinants (tobacco use, unhealthy diet, harmful use of alcohol, physical inactivity, social determinants), health service and primary health care (health system, primary health care and UHC, essential medicines and technologies for NCDs), NCD research and innovation, and public health and epidemiology (public health policies, epidemiology and disease burden) and with expertise in the following areas:

  • Raising the priority accorded to NCD in development work at global and national levels.
  • Developing national policies and plans for the prevention and control of NCDs and integrating the prevention and control of NCDs into policies across all government departments.
  • Integrating the prevention and control of NCDs into PHC and UHC.
  • Promoting interventions to reduce the main shared modifiable risk factors for NCDs.
  • Promoting partnerships for the prevention and control of NCDs.
  • Promote research for the prevention and control of NCDs.
  • Monitoring NCDs and their determinants and evaluating progress at the national, regional and global levels.

Existing STAG-NCD members can reapply for an additional term.

Submitting your expression of interest

To register your interest in being considered for the STAG-NCD, please submit the following documents by Friday 1 September 2023 at 23:59 (Geneva time) to NCDDepartment@who.int using the subject line “Expression of interest for the Strategic and Technical Advisory Group for the Prevention and Control of NCDs”:

  • A cover letter, indicating your motivation to apply and how you satisfy the selection criteria. Please note that, if selected, membership will be in a personal capacity. Therefore, do not use the letterhead or other identification of your employer.
  • Your curriculum vitae.
  • A signed and completed Declaration of interests (DOI) form for WHO experts, available at  https://www.who.int/about/ethics/declarations-of-interest.

After submission, your expression of interest will be reviewed by WHO. Due to an expected high volume of interest, only selected individuals will be informed. 

Important information about the selection processes and conditions of appointment

Members of WHO STAG-NCD must be free of any real, potential or apparent conflicts of interest. To this end, applicants are required to complete the WHO Declaration of interests for WHO experts, and the selection as a member of an STAG-NCD is, amongst other things, dependent on WHO determining that there is no conflict of interest or that any identified conflicts could be appropriately managed (in addition to WHO’s evaluation of an applicant’s experience, expertise and motivation and other criteria). 

All STAG-NCD members will serve in their individual expert capacity and shall not represent any governments, any commercial industries or entities, any research, academic or civil society organizations, or any other bodies, entities, institutions or organizations. They are expected to fully comply with the Code of Conduct for WHO Experts ( https://www.who.int/about/ethics/declarations-of-interest). STAG-NCD members will be expected to sign and return a completed confidentiality undertaking prior to the beginning of the first meeting.

At any point during the selection process, telephone interviews may be scheduled between an applicant and the WHO Secretariat to enable WHO to ask questions relating to the applicant’s experience and expertise and/or to assess whether the applicant meets the criteria for membership in the relevant STAG-NCD.

The selection of members of the STAG-NCD will be made by WHO in its sole discretion, taking into account  the following (non-exclusive) criteria: relevant technical expertise; experience in international and country policy work; communication skills; and ability to work constructively with people from different cultural backgrounds and orientations. The selection of STAG-NCD members will also take account of the need for diverse perspectives from different regions, especially from low and middle-income countries, and for gender balance.

If selected by WHO, proposed members will be sent an invitation letter and a memorandum of agreement. Appointment as a member of the STAG-NCD will be subject to the proposed member returning to WHO the countersigned copy of these 2 documents.

WHO reserves the right to accept or reject any expression of interest, to annul the open call process and reject all expressions of interest at any time without incurring any liability to the affected applicant or applicants and without any obligation to inform the affected applicant or applicants of the grounds for WHO’s action. WHO may also decide, at any time, not to proceed with the establishment of the STAG-NCD, disband an existing STAG-NCD or modify the work of the STAG-NCD. 

WHO shall not in any way be obliged to reveal, or discuss with any applicant, how an expression of interest was assessed, or to provide any other information relating to the evaluation/selection process or to state the reasons for not choosing a member.

WHO may publish the names and a short biography of the selected individuals on the WHO internet.

STAG-NCD members will not be remunerated for their services in relation to the STAG-NCD or otherwise. Travel and accommodation expenses of STAG-NCD members to participate in STAG-NCD meetings will be covered by WHO in accordance with its applicable policies, rules and procedures. 

The appointment will be limited in time as indicated in the letter of appointment.

If you have any questions about this “Call for experts”, please write to NCDDepartment@who.int well before the applicable deadline of 1 September 2023 at 23:59.

More Info: WHO



Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

  • World Water Day 2026 | Water & Gender Equality
  • Nepal Antimicrobial Resistance (AMR) Bulletin FY 2081/82
  • Call for applications! Short Course on Qualitative Research Methods in Public Health, 2026
  • World Obesity Day 2026 | 8 Billion Reasons to Act on Obesity
  • Salim Yusuf Emerging Leaders Programme 2026

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated



  • WordPress
  • Link
  • Facebook
  • Mail
  • Facebook
  • Twitter
  • Twitter
  • LinkedIn
  • Instagram
  • Facebook
July 1, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Improving access to water, sanitation and hygiene can save 1.4 million lives per year, says new WHO report
EnvironmentEnvironmental Health & Climate ChangePublic HealthPublic Health UpdateReportsResearch & Publication

Improving access to water, sanitation and hygiene can save 1.4 million lives per year, says new WHO report

by Public Health Update June 28, 2023
written by Public Health Update

28 June 2023

Half of the world’s population still does not have adequate access to safe drinking water, sanitation and hygiene (WASH) which could have prevented at least 1.4 million deaths and 74 million disability-adjusted life years in 2019, according to the latest report by the World Health Organization (WHO) and an accompanying article published in The Lancet.

“With growing WASH-related health risks seen already today through conflicts, the emergence of antimicrobial resistance, the re-emergence of cholera hotspots, and the long-term threats from climate change, the imperative to invest is stronger than ever” said Dr Maria Neira, Director, WHO Department of Environment, Climate Change and Health. “We have seen improvements in WASH service levels over the last 10 years, but progress is uneven and insufficient”

Burden of disease attributable to unsafe drinking water, sanitation, and hygiene: 2019 update presents estimates of the burden of disease attributable to unsafe drinking water, sanitation and hygiene for 183 WHO Member States disaggregated by region, age and sex for the year 2019. The estimates are based on four health outcomes – diarrhoea, acute respiratory infections, undernutrition, and soil-transmitted helminthiases. 

Diarrhoeal disease accounted for most of the attributable burden, with over one million deaths and 55 million DALYs.  The second largest contributor was acute respiratory infections from inadequate hand hygiene, which was linked to 356 000 deaths and 17 million DALYs.

Among children under five, unsafe WASH was responsible for 395 000 deaths and 37 million DALYs, representing 7.6% of all deaths and 7.5% of all DALYs in this age group. This included 273 000 deaths from diarrhoea and 112 000 deaths from acute respiratory infections. These diseases are the top two infectious causes of death for children under five globally.

Important disparities were noted between regions and income groups. More than three-quarters of all WASH-attributable deaths occurred in the WHO African and South-East Asia regions, while 89% of attributable deaths were from low- and lower-middle income countries. However, even high-income countries are at risk, as 18% of their diarrhoeal disease burden could be prevented through improved hand hygiene practices.

While these estimates included four health outcomes for which data were available to quantify the impact, the true burden is likely to be much higher. The impacts of unsafe WASH on health are wide-ranging and go beyond disease by affecting social and mental well-being. In addition, climate change is likely to exacerbate many WASH-related diseases and risks which are not fully captured in the present estimates.

To reduce the WASH-attributable burden of disease, WHO urges governments to take the following actions with support from UN agencies, multilateral partners, the private sector and civil society organizations: 

  • Radically accelerate action to make safe WASH a reality for all. The mid-term comprehensive review of the International Decade for Action Towards the Sustainable Development Goals saw renewed commitments from governments to accelerate progress towards the goal of universal access to safe WASH. By quantifying for the first time the health gains associated with higher WASH service levels, the updated estimates provide strong evidence to support efforts to take these commitments to action.
  • Focus efforts on the poorest and most disadvantaged. The burden of disease is largely driven by inadequate access in low- and middle- income countries, and national estimates on WASH access often hide disparities within countries. Access to WASH services is typically lower among rural populations and lower socio-economic groups. Even in high-income countries, where access to safely managed drinking-water and sanitation services is generally high, certain marginalized communities are underserved and face higher risks.
  • Adapt national monitoring systems to improve data on population exposure to safely managed services. Data on higher levels of WASH services remain sparse in many countries. Governments should adapt national and local monitoring systems taking into consideration the higher service levels called for in the SDG framework, enabling a more accurate reflection of the full burden of disease associated with unsafe WASH.

“It is clear that inadequate access to safe water, sanitation, and hygiene services continues to pose a significant, and preventable, health risk, particularly to the most vulnerable populations,” said Mr. Bruce Gordon, Head, WHO Water, Sanitation, Hygiene and Health Unit. “The health benefits, as quantified in the report, are immense. Prioritizing those most in need is not just a moral imperative; it is key to addressing the disproportionate disease burden in low and middle-income countries and among marginalized groups in high-income countries.”

To support governments, WHO also today released a new tool to model disease impacts from different WASH scenarios. The tool will foster informed policy-making, guide targeted interventions, and support strategic resource allocation for WASH programming.

Full Report here 
Lancet article here

Key data here

Country analytical tool here



Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

  • World Water Day 2026 | Water & Gender Equality
  • Nepal Antimicrobial Resistance (AMR) Bulletin FY 2081/82
  • Call for applications! Short Course on Qualitative Research Methods in Public Health, 2026
  • World Obesity Day 2026 | 8 Billion Reasons to Act on Obesity
  • Salim Yusuf Emerging Leaders Programme 2026

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated



  • WordPress
  • Link
  • Facebook
  • Mail
  • Facebook
  • Twitter
  • Twitter
  • LinkedIn
  • Instagram
  • Facebook
June 28, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
International Plan, Policy & GuidelinesNeglected Tropical Diseases (NTDs)Public Health UpdateResearch & Publication

First WHO guidance on snakebite treatments published

by Public Health Update June 25, 2023
written by Public Health Update

The World Health Organization (WHO) has published the first in a series of WHO public-benefit target product profiles (TPPs) for snakebite treatments, in order to improve the quality of antivenoms available in the market. This is the first-ever guidance to improve the quality of such products. The TPP is a document that provides regulators, manufacturers, researchers and procurement agencies with essential information about the minimum and optimum characteristics of specific products for specific use cases, in this case, antivenoms used for the treatment of snakebites caused by various types of sub-Saharan African snakes. TPPs help to ensure that products are designed and manufactured to meet the match the clinical needs of populations at risk, and are “fit-for-use” – e.g., are safe, effective and adapted to the use environment.

This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:

  • Broad spectrum Pan-African polyvalent antivenoms: products that are intended for widespread utility throughout sub-Saharan Africa for treatment of envenoming irrespective of the species of snake causing a bite.
  • Monovalent antivenoms for specific use cases: for products for a single species (or genus) of snake (e.g., boomslangs or carpet viper antivenoms).
  • Syndromic Pan-African polyvalent antivenoms for neurotoxic envenoming: products that are intended for treatment of envenoming by species whose venoms are neurotoxic.
  • Syndromic Pan-African polyvalent antivenoms for non-neurotoxic envenoming: products for snakebite envenoming where the effects are largely haemorrhagic, necrotic or procoagulant.

A high-quality antivenom provides the best available treatment for approximately 5.4 million people who are bitten by snakes each year. Safe, effective antivenoms could prevent many of the 83 000-138 000 deaths caused by snakebites and reduce the severity of serious disabilities that impact many thousands more victims.

“Access to high quality, safe and effective antivenom is an issue of equity and this critical work brings us one step forward in being able to make this a reality” Dr Socé Fall, Director of the WHO Global NTD Programme.

Antivenoms have been made for some 130 years and yet, remarkably, there has been until now, no guidance on how to design and manufacture a product of high quality that meets the correct requirements for safety, effectiveness, and functional use.

Four TPPs for different types of conventional animal plasma-derived antivenoms

The first of these is for products that are intended for widespread use throughout sub-Saharan Africa, for treatment of snakebites irrespective of the species of snake causing the bite. The second is for treatment of bites from a single species (or group) of snake(s). Products in both these categories are currently on the market.

The other two categories are for products that do not yet exist in sub-Saharan Africa, but evidence from other parts of the world suggests that if developed they may have a useful role to play. One of these new product types is for antivenoms where the snakebite mainly causes a syndrome dominated by neurotoxic effects, while the other is intended for non-neurotoxic snakebite syndromes that involve effects on blood clotting or tissue necrosis without paralytic effects.

These TPPs, are intended to provide guidance to manufacturers, regulators, procurement agencies, clinicians and researchers and will contribute to improvements in the quality, safety and effectiveness of antivenoms and thus better treatment of snakebites.

Download: Target product profiles for animal plasma-derived antivenoms: antivenoms for treatment of snakebite envenoming in sub-Saharan Africa


Do you have a website? Looking for the best hosting provider? Here’s a discount code.

Latest Public Health Jobs

Latest Posts

  • World Water Day 2026 | Water & Gender Equality
  • Nepal Antimicrobial Resistance (AMR) Bulletin FY 2081/82
  • Call for applications! Short Course on Qualitative Research Methods in Public Health, 2026
  • World Obesity Day 2026 | 8 Billion Reasons to Act on Obesity
  • Salim Yusuf Emerging Leaders Programme 2026

Thanks for visiting us.
Disclaimer: The resources, documents, guidelines, and information on this blog have been collected from various sources and are intended for informational purposes only. Information published on or through this website and affiliated social media channels does not represent the intention, plan, or strategies of an organization that the initiator is associated with in a professional or personal capacity, unless explicitly indicated.
If you have any complaints, information, or suggestions about the content published on Public Health Update, please feel free to contact us at blog.publichealthupdate@gmail.com.
#StayUpdated



  • WordPress
  • Link
  • Facebook
  • Mail
  • Facebook
  • Twitter
  • Twitter
  • LinkedIn
  • Instagram
  • Facebook
June 25, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Nepal Health Jobs! Latest trending health jobs and opportunities! Explore health jobs in Nepal
Call for Proposal, EOI & RFPEnvironmentEnvironmental Health & Climate ChangeInternational Jobs & OpportunitiesPublic Health OpportunitiesPublic Health Opportunity

Call for Experts: Consultant – Air pollution and health statistics

by Public Health Update June 25, 2023
written by Public Health Update

OBJECTIVES OF THE CONSULTANCY

To contribute to WHO’s custodial role in air pollution-related Sustainable Development Goals (SDG)’s indicators, i.e. 3.9.1 mortality from air pollution and – SDG 11.6.2 air quality in urban areas. The assigned duties include data analyses, monitoring and reporting activities, as well as interacting with WHO expert groups on air pollution and health to develop evidence-based tools and guidance to support countries tackling the health effects of air pollution.

BACKGROUND

The objective of the World Health Organization (WHO) Air Quality and Health (AQH) unit in the Department of Environment, Climate Change and Health is to promote health sector interventions, as well as interventions in economic sectors (e.g. housing, transport, energy) that reduce environmental health risks, promote better health, and optimize the health co-benefits of sustainable development and climate change mitigation policies. 

AQH activities aim to address the urgent need for the health sector to respond to the effects on health associated with air pollution. One of the key activities is to inform policymakers and the broad public on the extent of population exposure to and health impacts from poor air quality. Accordingly, WHO is custodial agency of three air pollution-related SDG Indicators and is hosting several databases related to ambient and household air pollution. 

WHO has established the Global Air Pollution and Health – Technical Advisory Group (GAPH-TAG) to work on the further development of activities related to health impacts assessments, desert dust and evidence-based interventions for air pollution, in which the SDG reporting is embedded. 

DELIVERABLES

• Deliverable 1: Update and maintain the WHO databases on air quality. 

• Deliverable 2: Derive or prepare datasets for SDG 3.9.1 and 11.6.2. 

• Deliverable 3: Prepare and format the estimates for SDG 3.9.1 and 11.6.1 for inclusion in the Global Health Observatory, UN Statistical reporting, as well as UN statistical commission reporting. 

• Deliverable 4: Facilitate technical responses on SDGs 3.9.1 and 11.6.2 and input data related queries. 

• Deliverable 5: Participate and contribute to the organization of the GAPH-TAG meetings related to health impact assessment, desert dust and intervention and policies. 

• Deliverable 6: Liaise with experts for the review and updates of methods for SDG 3.9.1 and 11.6.2. 

• Deliverable 7: Participate and contribute to the organization of the GAPH-TAG meetings related to health impact assessment, desert dust and intervention and policies. 

• Deliverable 8: Contribute to the development of tools to identify cost-effective interventions to address the health impact of air pollution. 

• Deliverable 9: Contribute to the development of a toolkit to address the health impact of ambient air pollution in line of what was done with household air pollution with the Clean Household Energy Solution Toolkit. 

QUALIFICATIONS, EXPERIENCE, SKILLS AND LANGUAGES

Education

Essential: Minimum first university degree in epidemiology, public health, chemistry or atmospheric science, environmental or health science, or another relevant quantitative field. 

Desirable: Postgraduate degree – or training in environmental health or epidemiology of air pollution

Experience

Essential:

• At least 7 years of practical work experience in air pollution, exposure assessment, health impact assessment, data management and quantitative analyses of large datasets and data cleaning. 

• Experience in data visualization. 

Desirable:

Experience working in a multicultural environment

Skills and knowledge  

• Proficiency in Microsoft Excel, including programming, Proficiency in Tableau, STATA or R; Shiny R and/or GIS. 

• Excellent knowledge of air pollution data, or environmental statistics, as well as other health-related SDG indicators, and a good understanding of data quality and limitations. 

• Excellent communication skills, both verbal and written. 

• Scientific technical writing as well as synthesis documents. 

• Ability to interact and maintain good working relationships with partners within and across organizations. 

• Organizational and planning skills. 

• Ability to work independently and in a proactive way. 

• Familiar with the WHO working environment. 

Use of Language Skills

Essential: Expert knowledge of English.
Desirable: Intermediate knowledge of French.

REMUNERATION

Band level B-USD 7,000 – USD 9,980 per month.

Primary Location:  Off-site – Home based.

Travel: The consultant is expected to travel. 

Expected duration of the contract: 6 months. 

SUBMITTING YOUR EXPRESSION OF INTEREST

Kindly apply through WHO Stellis system searching for the following position:

Consultant – Air pollution and health statistics – (2305324)

ADDITIONAL INFORMATION

  • This vacancy notice may be used to fill other similar positions at the same grade level
  • Only candidates under serious consideration will be contacted.
  • A written test may be used as a form of screening.
  • In the event that your candidature is retained for an interview, you will be required to provide, in advance, a scanned copy of the degree(s)/diploma(s)/certificate(s) required for this position. WHO only considers higher educational qualifications obtained from an institution accredited/recognized in the World Higher Education Database (WHED), a list updated by the International Association of Universities (IAU)/United Nations Educational, Scientific and Cultural Organization (UNESCO). The list can be accessed through the link: http://www.whed.net/. Some professional certificates may not appear in the WHED and will require individual review.
  • According to article 101, paragraph 3, of the Charter of the United Nations, the paramount consideration in the employment of the staff is the necessity of securing the highest standards of efficiency, competence, and integrity. Due regard will be paid to the importance of recruiting the staff on as wide a geographical basis as possible.
  • Any appointment/extension of appointment is subject to WHO Staff Regulations, Staff Rules and Manual.
  • Staff members in other duty stations are encouraged to apply.
  • For information on WHO’s operations please visit: http://www.who.int.
  • The WHO is committed to creating a diverse and inclusive environment of mutual respect. The WHO recruits and employs staff regardless of disability status, sex, gender identity, sexual orientation, language, race, marital status, religious, cultural, ethnic and socio-economic backgrounds, or any other personal characteristics.
  • The WHO is committed to achieving gender parity and geographical diversity in its staff. Women, persons with disabilities, and nationals of unrepresented and underrepresented Member States (https://www.who.int/careers/diversity-equity-and-inclusion)are strongly encouraged to apply for WHO jobs.
  • Persons with disabilities can request reasonable accommodations to enable participation in the recruitment process. Requests for reasonable accommodation should be sent through an email to reasonableaccommodation@who.int
  • An impeccable record for integrity and professional ethical standards is essential. WHO prides itself on a workforce that adheres to the highest ethical and professional standards and that is committed to put the WHO Values Charter into practice.
  • WHO has zero tolerance towards sexual exploitation and abuse (SEA), sexual harassment and other types of abusive conduct (i.e., discrimination, abuse of authority and harassment). All members of the WHO workforce have a role to play in promoting a safe and respectful workplace and should report to WHO any actual or suspected cases of SEA, sexual harassment and other types of abusive conduct. To ensure that individuals with a substantiated history of SEA, sexual harassment or other types of abusive conduct are not hired by the Organization, WHO will conduct a background verification of final candidates.
  • Mobility is a condition of international professional employment with WHO and an underlying premise of the international civil service. Candidates appointed to an international post with WHO are subject to mobility and may be assigned to any activity or duty station of the Organization throughout the world.
  • WHO also offers wide range of benefits to staff, including parental leave and attractive flexible work arrangements to help promote a healthy work-life balance and to allow all staff members to express and develop their talents fully.
  • The statutory retirement age for staff appointments is 65 years. For external applicants, only those who are expected to complete the term of appointment will normally be considered.
  • WHO has a smoke-free environment and does not recruit smokers or users of any form of tobacco.
  • In case the website does not display properly, please retry by: (i) checking that you have the latest version of the browser installed (Chrome, Edge or Firefox); (ii) clearing your browser history and opening the site in a new browser (not a new tab within the same browser); or (iii) retry accessing the website using Mozilla Firefox browser or using another device.

Deadline: June 27, 2023

June 25, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Nepal Health Jobs! Latest trending health jobs and opportunities! Explore health jobs in Nepal
Call for Proposal, EOI & RFPInternational Jobs & OpportunitiesPublic HealthPublic Health OpportunitiesPublic Health Opportunity

Call for Experts – Technical Advisory Group on Genomics

by Public Health Update June 25, 2023
written by Public Health Update

The World Health Organization (WHO) is seeking experts to serve as members one of the Technical Advisory Group on Genomics. This “Call for experts” provides information about the advisory group in question, the expert profiles being sought, the process to express interest, and the process of selection.

Background

In 2021, WHO Director-General (DG) Dr Tedros Adhanom Ghebreyesus established the Science Council to advise him on WHO’s scientific agenda. At its first meeting, the Science Council identified genomics as the focus of its first report, for a number of compelling reasons, chief among them, the substantial and extensive benefits of genomics for personal and public health. In its report ‘Accelerating access to genomics for global health’, the Science Council made 15 recommendations to the WHO grouped into four categories: Promotion of genomics through advocacy; implementation of genomic methodologies; collaboration among entities engaged in genomics; and attention to the ethical, legal, and social issues (ELSIs) raised by genomics. One of the key recommendations of this report was for the WHO to form a genomics advisory group primarily to assess and report annually to the WHO Secretariat on progress in implementing the recommendations from this report. The WHO is now seeking to form a Technical Advisory Group on Genomics in response to this recommendation. The group’s main, but not exclusive, focus will be on human genomics. This Technical Advisory Group will advise the Secretariat on the work in this field.

Functions of the Technical Advisory Group on Genomics

In its capacity as an advisory group to the WHO, the Technical Advisory Group will have the following functions:

  • Support and provide technical guidance on activities implemented by the WHO Secretariat to accelerate access to genomics technologies for global health, with a particular focus on human genomics;
  • Review and recommend priority activities for consideration by WHO in order to accelerate access to genomics technologies for global health, including promotion and advocacy in addition to technical activities;
  • Contribute to, and advise the WHO Secretariat’s on efforts in convening discussions by scientists, policymakers, patient advocates, clinicians, lawyers, ethicists, and others to develop genomics-related guidance and reports;
  • Support WHO to bringing attention to regional and sub-regional opportunities and experiences in genomics;
  • Contribute to assessing, and report annually to the WHO Secretariat, on progress in accelerating access to genomics for global health;
  • Undertake other duties and functions consistent with these Terms of Reference, when requested by the WHO Secretariat.

Operations of the Technical Advisory Group on Genomics

The Technical Advisory Group on Genomics shall meet at least three times each year. However, WHO may convene additional meetings. Meetings may be held in person (at WHO headquarters in Geneva or another location, as determined by WHO) or virtually, via video or teleconference. The working language will be English.

Who can express interest?

The Technical Advisory Group on Genomics will be multidisciplinary, with members who have a range of technical knowledge, skills and experience relevant to Genomics with main, but not exclusive, focus on human genomics. Up to 15 members may be selected.

WHO welcomes expressions of interest from:

Scientists, healthcare professionals, and healthcare regulators with expertise in a diverse set of fields related to genomics (and in particular human genomics), including the following areas

  • Cancer, common complex diseases and other non-communicable diseases
  • Congenital disorders and rare diseases
  • Human genomic variation and host-determinants of infections
  • Pharmacogenomics and toxicogenomics
  • Epigenomics
  • Human microbiome
  • R&D in the field of genome-based knowledge and technologies with a focus on human genomics
  • Translation/implementation of genome-based technologies into clinical practice
  • Ethics, law, and other relevant social science domains, related to human genomics
  • One Health approach to genomics, with a focus on linking human genomics with pathogen and/or environmental genomics

Submitting your expression of interest

To register your interest in being considered for the Technical Advisory Group on Genomics, please submit the following documents by 23:59 Geneva time on 16 July 2023 to genomics@who.int using the subject line “Expression of interest for the Technical Advisory Group on Genomics”:

  • A cover letter, indicating your motivation to apply and how you satisfy the selection criteria. Please note that, if selected, membership will be in a personal capacity. Therefore, do not use the letterhead or other identification of your employer);
  • Your curriculum vitae of maximum 2 pages; and
  • A signed and completed Declaration of Interests (DOI) form for WHO Experts, available at https://www.who.int/about/ethics/declarations-of-interest.

After submission, your expression of interest will be reviewed by WHO.  Due to an expected high volume of interest, only selected individuals will be informed. 

Important information about the selection processes and conditions of appointment

Members of WHO advisory groups (AGs) must be free of any real, potential or apparent conflicts of interest. To this end, applicants are required to complete the WHO Declaration of Interests for WHO Experts, and the selection as a member of a AG is, amongst other things, dependent on WHO determining that there is no conflict of interest or that any identified conflicts could be appropriately managed (in addition to WHO’s evaluation of an applicant’s experience, expertise and motivation and other criteria).

All AG members will serve in their individual expert capacity and shall not represent any governments, any commercial industries or entities, any research, academic or civil society organizations, or any other bodies, entities, institutions or organizations. They are expected to fully comply with the Code of Conduct for WHO Experts (https://www.who.int/about/ethics/declarations-of-interest). AG members will be expected to sign and return a completed confidentiality undertaking prior to the beginning of the first meeting.

At any point during the selection process, telephone interviews may be scheduled between an applicant and the WHO Secretariat to enable WHO to ask questions relating to the applicant’s experience and expertise and/or to assess whether the applicant meets the criteria for membership in the relevant AG.

The selection of members of the AGs will be made by WHO in its sole discretion, taking into account  the following (non-exclusive) criteria: relevant technical expertise; experience in international and country policy work; communication skills; and ability to work constructively with people from different cultural backgrounds and orientations .The selection of AG members will also take account of the need for diverse perspectives from different regions, especially from low and middle-income countries, and for gender balance.

If selected by WHO, proposed members will be sent an invitation letter and a Memorandum of Agreement. Appointment as a member of a AG will be subject to the proposed member returning to WHO the countersigned copy of these two documents.

WHO reserves the right to accept or reject any expression of interest, to annul the open call process and reject all expressions of interest at any time without incurring any liability to the affected applicant or applicants and without any obligation to inform the affected applicant or applicants of the grounds for WHO’s action. WHO may also decide, at any time, not to proceed with the establishment of the AG, disband an existing TAG or modify the work of the AG.

WHO shall not in any way be obliged to reveal, or discuss with any applicant, how an expression of interest was assessed, or to provide any other information relating to the evaluation/selection process or to state the reasons for not choosing a member.

WHO may publish the names and a short biography of the selected individuals on the WHO internet.

AG members will not be remunerated for their services in relation to the AG or otherwise. Travel and accommodation expenses of AG members to participate in AG meetings will be covered by WHO in accordance with its applicable policies, rules and procedures.

The appointment will be limited in time as indicated in the letter of appointment.

If you have any questions about this “Call for experts”, please write to genomics@who.int well before the applicable deadline. 

Deadline: 16 July 2023

June 25, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Nepal Health Jobs! Latest trending health jobs and opportunities! Explore health jobs in Nepal
Call for Proposal, EOI & RFPCommunicable DiseasesInternational Jobs & OpportunitiesOpportunities by RegionPublic HealthPublic Health OpportunitiesPublic Health Opportunity

Call for Experts: Technical Advisory Group on dosing of TB medicines for adults and children

by Public Health Update June 25, 2023
written by Public Health Update

The World Health Organization is seeking experts to serve as members of the Technical Advisory Group on dosing of TB medicines for adults and children. This “Call for Experts” provides information about the advisory group, the expert profiles being sought, the process for experts to express interest, and the process of selection. 

Background 

Tuberculosis (TB) remains one of the world’s deadliest infectious killers and is a major cause of ill health and suffering. Until the coronavirus disease (COVID-19) pandemic, TB was the top cause of death due to a single infectious agent. In 2021, an estimated 10.6 million people fell ill with TB, (including 1.15 million children) and 1.6 million people died of TB. Globally, the success rate for people treated for TB in 2020 was 86%. However, without treatment, the death rate from TB disease is high (about 50%). The burden of drug-resistant forms of TB is estimated to have increased between 2020 and 2021, with an estimated 450 000 new cases of rifampicin-resistant TB (RR-TB) in 2021. Stopping TB infection from progressing to disease through the use of TB preventive treatment (TPT) is a critical and effective intervention to reduce TB incidence to the levels envisaged by WHO’s End TB Strategy. 

Recent years have seen significant advances in scientific evidence generated on shorter regimens for both TB treatment and TB prevention. Results from several studies have informed WHO recommendations on regimens for drug-susceptible TB with a duration as short as 4 months and for regimens for MDR/RR-TB with a duration as short as 6 months, as well as TPT regimens with a duration down to 1 month. Access to shorter, simpler regimens is a key aspect to improve people-centred TB care. 

To keep pace with these developments, WHO’s Global Tuberculosis Programme develops evidence-informed policy as new evidence becomes available. As many of the new policy recommendations on treatment and prevention are at the cutting edge of science, important practical questions remain related to implementation, which are beyond the scope of the WHO guideline development process, and which require additional evidence and critical evaluation from technical experts.  

In parallel to new evidence being generated that informs WHO recommendations, several studies have been conducted or are ongoing to optimize TB medicine dosing strategies and drug delivery approaches among children and adults, given available formulations of TB medicines and considering particularly vulnerable populations, such as people with HIV and those with severe forms of extra-pulmonary TB. 

In this context, a Technical Advisory Group on the dosing of TB medicines for adults and children, comprising experts on pharmacokinetics/pharmacodynamics, as well as pharmacometricians, researchers, clinicians, including pediatricians, as well as people with experience in the programmatic management of TB in various settings, with the mandate and principles set out below, is being convened by WHO to advise on dosing issues related to TB medicines for all ages and for all indications, aligned to WHO recommendations. 

Functions of the Technical Advisory Group on dosing of TB medicines for adults and children 

  1. To provide an independent evaluation and advice to WHO on scientific and technical aspects of dosing of anti-tuberculosis medicines for children and adults with all forms of TB, aligned to WHO recommendations and based on the latest available scientific evidence with the aim to optimize the dosing of TB medicines and the operational guidance on their use by country programmes; 
  1. To advise WHO on the new developments in the dosing and drug delivery approaches of medicines used in TB care.   

Operations of the Technical Advisory Group on dosing of TB medicines for adults and children 

The Technical Advisory Group shall normally meet once each year. However, WHO may convene additional meetings, when needed. Meetings may be held in person (at WHO headquarters in Geneva or another location, as determined by WHO) or virtually, via videoconference. Sessions dealing with advice to WHO shall be restricted to the members of the Technical Advisory Group and essential WHO Secretariat staff. Open sessions shall be convened for the sole purpose of the exchange of non-confidential information and views and may be attended by Observers. Membership in the Technical Advisory Group may be terminated at any time by WHO, if WHO’s interest so requires, or for any of the following reasons: 

1. failure to attend two consecutive meetings of the Technical Advisory Group; 

2. a conflict of interest incompatible with serving on the Technical Advisory Group; and 

3. a lack of professionalism involving, for example, a breach of confidentiality. 

For additional information about the operations of the Technical Advisory Group on dosing of TB medicines for adults and children, please see the Terms of Reference.

Who can express interest? 

The Technical Advisory Group on dosing of TB medicines for adults and children will be multidisciplinary, with members who have a broad range of technical knowledge, skills and experience relevant to optimizing TB medicine dosing in children and adults with TB or at risk of TB. Approximately 20 members may be selected.  

WHO welcomes expressions of interest from: 

Experts, from high and low TB-burden settings, with an excellent track record and expertise in one or more of the following areas as they relate to TB medicines and studies: 

  • Clinical pharmacology 
  • Pharmacokinetics/pharmacodynamics 
  • Pharmacometrics 
  • Clinical research 
  • Clinical medicine with experience in tuberculosis (including but not limited to infectious disease specialists, paediatricians and pulmonologists) 

In addition, to ensure that the perspectives and needs of people with TB and communities are considered in any of the decisions made by this Technical Advisory Group, persons with a lived experience of TB or experience in civil society organisations and a strong record leading community activities on patient care and TB prevention or treatment are also invited to submit their applications in their personal/individual capacity and not as representatives of their institutions. 

Submitting your expression of interest 

To register your interest for consideration as a member of the Technical Advisory Group on dosing of TB medicines for adults and children, please submit the following documents by 14 July 2023, 23:59 CEST via the online application available here. 

  • A cover letter, indicating your motivation to apply and how you satisfy the selection criteria. Please note that, if selected, membership will be in an individual capacity. Therefore, it is recommended that applicants do not use the letterhead or other identification of their employer. 
  • Your curriculum vitae (maximum 4 pages, including key publications in the technical areas relevant for the work of this TAG); and 
  • A signed and completed Declaration of Interests (DOI) form for WHO Experts, available at here.

Please prepare the required documents and save them in PDF format. The online application allows you to save your responses and attachments, but make sure to return to complete it later and submit it. After submission, your expression of interest will be reviewed by WHO. Due to an expected high volume of interest, only selected individuals will be informed of the outcome of the selection process.

Important information about the selection processes and conditions of appointment 

Members of WHO advisory groups (AGs) must be free of any real, potential or apparent conflicts of interest. To this end, applicants are required to complete the WHO Declaration of Interests for WHO Experts, and the selection as a member of an AG is, among other things, dependent on WHO determining that there is no conflict of interest or that any identified conflicts could be appropriately managed (in addition to WHO’s evaluation of an applicant’s experience, expertise and motivation and other criteria).  

All AG members will serve in their individual expert capacity and shall not represent any governments, any commercial industries or entities, any research, academic or civil society organizations, or any other bodies, entities, institutions or organizations. They are expected to fully comply with the Code of Conduct for WHO Experts. AG members will be expected to sign and return a completed confidentiality undertaking prior to the beginning of the first meeting. 

At any point during the selection process, telephone interviews may be scheduled between an applicant and the WHO Secretariat to enable WHO to ask questions relating to the applicant’s experience and expertise and/or to assess whether the applicant meets the criteria for membership in the relevant AG. 

The selection of members of the AGs will be made by WHO in its sole discretion, taking into account the following (non-exclusive) criteria: relevant technical expertise; experience in international and country policy work; communication skills; and ability to work constructively with people from different cultural backgrounds and orientations. The selection of AG members will also take account of the need for diverse perspectives from different regions, especially from low and middle-income countries, and for gender balance. 

If selected by WHO, proposed members will be sent an invitation letter and a Memorandum of Agreement. Appointment as a member of an AG will be subject to the proposed member returning to WHO the countersigned copy of these two documents. 

WHO reserves the right to accept or reject any expression of interest, to annul the open call process and reject all expressions of interest at any time without incurring any liability to the affected applicant or applicants and without any obligation to inform the affected applicant or applicants of the grounds for WHO’s action. WHO may also decide, at any time, not to proceed with the establishment of the AG, disband an existing TAG or modify the work of the AG.  

WHO shall not in any way be obliged to reveal, or discuss with any applicant, how an expression of interest was assessed, or to provide any other information relating to the evaluation/selection process or to state the reasons for not choosing a member. 

WHO may publish the names and a short biography of the selected individuals on the WHO internet. 

AG members will not be remunerated for their services in relation to the AG or otherwise. Travel and accommodation expenses of AG members to participate in AG meetings will be covered by WHO in accordance with its applicable policies, rules and procedures.  

The appointment will be limited in time as indicated in the letter of appointment. 

If you have any questions about this “Call for Experts”, please write to GTBPCI@who.int well before the applicable deadline. 
Deadline: 14 July 2023.

June 25, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Public Health Opportunity! Explore world's trending global health opportunities! Visit us for latest public health opportunities.
Call for Proposal, EOI & RFPInternational Jobs & OpportunitiesNon- Communicable Diseases (NCDs)Public HealthPublic Health OpportunitiesPublic Health Opportunity

Call for Experts: Technical Advisory Group on Diabetes

by Public Health Update June 25, 2023
written by Public Health Update

WHO

The World Health Organization (WHO) is seeking experts to serve as members of the Technical Advisory Group on Diabetes (TAG-D). This “Call for experts” provides information about the TAG-D, the expert profiles being sought, the process to express interest, and the process of selection.

Background

The TAG-D was established in August 2021 to act as an advisory body to WHO to further WHO’s leadership and coordination role in promoting and monitoring global action against diabetes.

The aim is to strengthen international and national action in this important public health area and thereby (1) reduce premature mortality from diabetes through prevention and treatment [1] and (2) progressively cover additional people with health services, medicines, vaccines, diagnostics and health technologies for the prevention and control of diabetes, [2], and (3) strengthen efforts to address diabetes as part of Universal Health Coverage (UHC). [3]

In April 2021, WHO established the Global Diabetes Compact, which has the vision of reducing the risk of diabetes and ensuring that all people who are diagnosed with diabetes have access to equitable, comprehensive, affordable and quality treatment and care. [4] As part of this initiative, global coverage targets for diabetes have been established. [5]

The first group of experts in the TAG-D have completed the 2-year term as per terms of reference. An open call for expressions of interest by suitable experts for the next term is therefore required.

Functions of the Technical Advisory Group on Diabetes

In its capacity as an advisory body to WHO, TAG-D shall have the following functions:

  • to identify and describe current and future challenges;
  • to advise WHO on strategic directions to be prioritized;
  • to advise WHO on the development of global strategic documents; and
  • to propose other strategic interventions and activities for implementation by WHO.

Operations of the Technical Advisory Group on Diabetes

The TAG-D shall normally meet twice per year. However, WHO may convene additional meetings. Meetings may be held in person (at WHO headquarters in Geneva or another location, as determined by WHO) or virtually, via video or teleconference.

TAG-D members are expected to attend meetings. If a member misses two consecutive meetings, WHO may end his/her appointment as a member of the TAG-D.

Active participation is expected from all TAG-D members, including in teleconferences, and interaction over email. Members may, in advance of meetings, be requested to review meeting documentation and to provide their views for consideration by the TAG-D.

The TAG-D meetings will be conducted in English. All documentation, including reports and working documents, will be provided in English.

The TAG-D will be multidisciplinary, with members who have a range of technical knowledge, skills and experience relevant to the important areas mentioned below. Up to 12 members may be selected.

WHO welcomes expressions of interest from:

Scientists, public health experts, healthcare professionals, innovators and policy-makers representing the broad range of disciplines relevant to diabetes including but not limited to expertise on early diagnosis and treatment, prevention, and cure for diabetes (and co-morbidities) with expertise in the following areas:

  • Major obstacles faced by countries to achieving global coverage targets for diabetes by 2030 and in the WHO global action plan on the prevention and control of NCDs (2013–2030).
  • Access to insulin, including WHO prequalification of insulin, industry approaches to price-setting, payer-approaches to price-setting, relationship between inputs throughout the “value chain” and price-setting, impacts on price, availability, affordability, research and development, and price transparency, unintended negative consequences, options that might enhance affordability and accessibility.
  • Recommendations on how to strengthen the prevention of type 2 diabetes in countries.
  • Recommendation on how to strengthen early detection and treatment of diabetes, including management of complications, in countries.
  • Recommendations on how to strengthen surveillance of diabetes, in countries.

Existing TAG-D members can reapply for an additional term. 

Submitting your expression of interest

To register your interest in being considered for the TAG-D, please submit the following documents by Thursday 13 July 2023 at 23:59 (Geneva time) to NCDDepartment@who.int using the subject line “Expression of interest for the Technical Advisory Group on Diabetes”:

  • A cover letter, indicating your motivation to apply and how you satisfy the selection criteria. Please note that, if selected, membership will be in a personal capacity. Therefore, do not use the letterhead or other identification of your employer.
  • Your curriculum vitae.
  • A signed and completed Declaration of Interests (DOI) form for WHO Experts, available at  https://www.who.int/about/ethics/declarations-of-interest.

After submission, your expression of interest will be reviewed by WHO. Due to an expected high volume of interest, only selected individuals will be informed.

Important information about the selection processes and conditions of appointment

Members of WHO TAG-D must be free of any real, potential or apparent conflicts of interest. To this end, applicants are required to complete the WHO Declaration of Interests for WHO Experts, and the selection as a member of TAG-D is, amongst other things, dependent on WHO determining that there is no conflict of interest or that any identified conflicts could be appropriately managed (in addition to WHO’s evaluation of an applicant’s experience, expertise and motivation and other criteria).

All TAG-D members will serve in their individual expert capacity and shall not represent any governments, any commercial industries or entities, any research, academic or civil society organizations, or any other bodies, entities, institutions or organizations. They are expected to fully comply with the Code of Conduct for WHO Experts (https://www.who.int/about/ethics/declarations-of-interest). TAG-D members will be expected to sign and return a completed confidentiality undertaking prior to the beginning of the first meeting.

At any point during the selection process, telephone interviews may be scheduled between an applicant and the WHO Secretariat to enable WHO to ask questions relating to the applicant’s experience and expertise and/or to assess whether the applicant meets the criteria for membership in the relevant TAG-D.

The selection of members of the TAG-D will be made by WHO in its sole discretion, taking into account the following (non-exclusive) criteria: relevant technical expertise; experience in international and country policy work; communication skills; and ability to work constructively with people from different cultural backgrounds and orientations. The selection of TAG-D members will also take account of the need for diverse perspectives from different regions, especially from low- and middle-income countries, and for gender balance.

If selected by WHO, proposed members will be sent an invitation letter and a Memorandum of Agreement. Appointment as a member of TAG-D will be subject to the proposed member returning to WHO the countersigned copy of these 2 documents.

WHO reserves the right to accept or reject any expression of interest, to annul the open call process and reject all expressions of interest at any time without incurring any liability to the affected applicant or applicants and without any obligation to inform the affected applicant or applicants of the grounds for WHO’s action. WHO may also decide, at any time, not to proceed with the establishment of the TAG-D, disband an existing TAG-D or modify the work of the TAG-D.

WHO shall not in any way be obliged to reveal, or discuss with any applicant, how an expression of interest was assessed, or to provide any other information relating to the evaluation/selection process or to state the reasons for not choosing a member.

WHO may publish the names and a short biography of the selected individuals on the WHO Internet.

TAG-D members will not be remunerated for their services in relation to the TAG-D or otherwise. Travel and accommodation expenses of TAG-D members to participate in TAG-D meetings will be covered by WHO in accordance with its applicable policies, rules and procedures.

The appointment will be limited in time as indicated in the letter of appointment.

If you have any questions about this “Call for experts”, please write to hemmingsenb@who.int well before the applicable deadline of 13 July 2023 at 23:59.

Notes:

[1] In accordance with SDG targets 3.4 (NCDs and its risk factors), 3.5 (harmful use of alcohol), 3.8 (UHC) and 3.a (tobacco control) of the 2030 Agenda for Sustainable Development.

[2] In accordance with paragraph 24(a) of A/RES/74/2.

[3] In accordance with paragraph 33 of A/RES/74/2.

[4] The WHO Global Diabetes Compact webpage https://www.who.int/initiatives/the-who-global-diabetes-compact[5] First-ever global coverage targets for diabetes adopted at the 75th World Health Assembly https://www.who.int/news-room/feature-stories/detail/first-ever-global-coverage-targets-for-diabetes-adopted-at-the-75-th-world-health-assembly
WHO

June 25, 2023 0 comments
0 FacebookTwitterPinterestLinkedinTumblrVKOdnoklassnikiRedditStumbleuponWhatsappTelegramLINEPocketSkypeViberEmail
Newer Posts
Older Posts

Search

Follow Us

Facebook Twitter Instagram Pinterest Linkedin Youtube

Categories

  • Abstracts (25)
  • Activities (91)
  • Adolescent Sexual and Reproductive Health (ASRH) (25)
  • Advice & Tips (3)
  • African Region (5)
  • AI and Health (1)
  • Annual Meeting (6)
  • Antimicrobial Resistance (AMR) (21)
  • Award (19)
  • Awards (16)
  • Books (9)
  • Call for Proposal, EOI & RFP (103)
  • Call for Research Participants (8)
  • Clinical Doctor Jobs (6)
  • Communicable Diseases (107)
  • Competition (20)
  • Conference (128)
  • Consultant (1)
  • Courses (205)
  • Dashboard (2)
  • Digital Health & Health Informatics (10)
  • Drug and Medicine (18)
  • Eastern Mediterranean Region (3)
  • Education (15)
  • Environment (3)
  • Environmental Health & Climate Change (47)
  • European Region (42)
  • Exchange Program (1)
  • Fact Sheet (117)
  • FCHVs (1)
  • Fellowships, Studentship & Scholarships (168)
  • Financial Aid (13)
  • Form Formats (2)
  • Fully funded (22)
  • Global Health News (433)
  • Grants and Funding Opportunities (193)
  • Guest Post (44)
  • Health Assistant Jobs (1)
  • Health Equity (7)
  • Health Financing and Economics (24)
  • Health in Data (115)
  • Health Insurance (5)
  • Health Jobs (52)
  • Health Literacy, Health Education & Promotion (49)
  • Health Organization Profile (42)
  • Health Systems (83)
  • Human Resource for Health (33)
  • Humanitarian Health & Emergency Response (44)
  • Hypertension (5)
  • Implementation Research (48)
  • International Health (3)
  • International Jobs & Opportunities (373)
  • International Plan, Policy & Guidelines (210)
  • Internships (4)
  • Jobs Vacancies (56)
  • Journals (8)
  • Life Style & Public Health Nutrition (39)
  • Live (10)
  • Master's Degree (48)
  • Maternal, Newborn and Child Health (88)
  • Mentorship Program (2)
  • Miscellaneous (16)
  • National Health News (157)
  • National Plan, Policy & Guidelines (468)
  • Neglected Tropical Diseases (NTDs) (51)
  • Non- Communicable Diseases (NCDs) (120)
  • Notice (103)
  • Nursing Jobs (6)
  • Nutritionist Jobs (1)
  • One Health (17)
  • Online & Distance Learning (22)
  • Online Courses (90)
  • Op-Ed Article (3)
  • Opportunities by Region (83)
  • Outbreak News (213)
  • Partially funded (6)
  • PCL Health Science Jobs (3)
  • PH Important Day (533)
  • Pharmacist Jobs (3)
  • PhD (54)
  • Photos (5)
  • Planetary Health (4)
  • PostDoc (14)
  • Presentation Slides (26)
  • Primary Health Care (25)
  • Provincial Plan, Policies and Guidelines (14)
  • Public Health (1,281)
  • Public Health Epidemiology & Biostatistics (13)
  • Public Health Events (306)
  • Public Health Information (20)
  • Public Health Innovation (9)
  • Public Health Jobs (52)
  • Public Health News (552)
  • Public Health Notes (120)
  • Public Health Opportunities (507)
  • Public Health Opportunity (491)
  • Public Health Programs (108)
  • Public Health Seminar (2)
  • Public Health Tools (1)
  • Public Health Update (561)
  • Quality Improvement & Infection Prevention (20)
  • Region of America (8)
  • Reports (184)
  • Research & Project Grants (39)
  • Research & Project Grants (32)
  • Research & Publication (647)
  • Research Articles (10)
  • Road Traffic Accidents (RTA) (9)
  • School of Public Health (60)
  • Self funded (2)
  • South-East Asia Region (26)
  • Success Stories (17)
  • Summer and Winter Courses (40)
  • Summer Courses (28)
  • Sustainable Development Goals (SDGs) (14)
  • Syllabus (61)
  • Symposium (9)
  • Tobacco Control (35)
  • Training (40)
  • Travel Grants (15)
  • Trick, Technique & Skills (8)
  • Uncategorized (3)
  • Undergraduate Degree (7)
  • Universal Health Coverage (36)
  • Universities (29)
  • Universities & School of Public Health (58)
  • Vacancy Announcement (26)
  • Vaccine Preventable Diseases (40)
  • Vector-Borne Diseases(VBDs) (30)
  • Videos (3)
  • View Points (1)
  • Webinar (4)
  • Western Pacific Region (13)
  • Workshop (18)
  • World News (116)
Post New Jobs: Vacancy Announcement Service
Post New Jobs: Vacancy Announcement Service

Public Health Update (Sagun’s Blog) is a popular public health portal in Nepal. Thousands of health professionals are connected with Public Health Update to get up-to-date public health updates, search for jobs, and explore opportunities.
#1 Public Health Blog for sharing Job opportunities and updates in Nepal

”Public Health Information For All”
– – Sagun Paudel, Founder

  • HOT JOBS
    • Public Health Jobs
    • Medical Doctor Jobs
    • Nursing Jobs
    • Health Assistant Jobs
    • Pharmacist Jobs
    • NGOs Jobs
    • Government Jobs
  • Top Categories
    • National Plan, Policy & Guidelines Top
    • Public Health Calendar
    • Fellowships & Scholarships
    • Health Systems
    • Health Organization Profiles
    • International Jobs & Opportunities
    • Public Health Opportunity

PUBLIC HEALTH INITIATIVE

    • Submit your Vacancies New
    • Partnership Opportunities

Contact: blog.publichealthupdate@gmail.com

https://wa.me/+9779856036932

Public Health Initiative, A Registered Non-profit organization – All Right Reserved. 2011-2024. Contact us. 

Facebook Twitter Instagram Youtube Envelope
Public Health Update
  • Home
  • Public Health
    • Home 1
      • Adolescent Sexual and Reproductive Health (ASRH)
      • Antimicrobial Resistance (AMR)
      • Communicable Diseases
      • Digital Health & Health Informatics
      • Environmental Health & Climate Change
      • Health Financing and Economics
      • Health Equity
    • Home 2
      • Health Literacy, Health Education & Promotion
      • Human Resource for Health
      • Humanitarian Health & Emergency Response
      • Implementation Research
      • International Health
      • Life Style & Public Health Nutrition
      • Maternal, Newborn and Child Health
    • Home 3
      • Neglected Tropical Diseases (NTDs)
      • Non- Communicable Diseases (NCDs)
      • One Health
      • Planetary Health
      • Public Health Epidemiology & Biostatistics
      • Primary Health Care
      • Quality Improvement & Infection Prevention
    • Home 4
      • Road Traffic Accidents (RTA)
      • Sustainable Development Goals (SDGs)
      • Tobacco Control
      • Universal Health Coverage
      • Vaccine Preventable Diseases
      • Vector-Borne Diseases(VBDs)
      • Notices
  • Public Health Update
    • Home 1
      • Public Health News
      • Global Health News
      • Outbreak News
      • National Health News
      • COVID-19
    • Home 2
      • Fact Sheet
      • Health in Data
      • PH Important Day
      • Public Health Events
      • Public Health Programs
    • Home 3
      • Health Systems
      • Health Insurance
      • Health Organization Profile
      • Success Stories
      • Public Health Innovation
  • Public Health Opportunities
    • Fully funded
    • Travel Grants
    • Grants and Funding Opportunities
    • Opportunities by Region
    • International Jobs & Opportunities
    • Research & Project Grants
    • Fellowships, Studentship & Scholarships
    • Conference
  • Jobs
    • Home 1
      • Health Jobs
      • Public Health Jobs
      • Clinical doctor Jobs
      • Health Assistant Jobs
      • Nursing Jobs
      • PCL Health Science Jobs
    • Home 2
      • Dental Jobs
      • Pharmacist Jobs
      • TSLC (Health Jobs)
      • Laboratory Jobs
      • Nutritionist Jobs
  • Downloads
    • International Plan, Policy & Guidelines
    • National Plan, Policy & Guidelines
    • Reports
    • Books
    • Research Articles
  • School of Public Health
    • Home 1
      • Courses
      • Master’s Degree
      • Undergraduate Degree
      • PhD
    • Home 2
      • Universities
      • Syllabus
      • Public Health Notes
      • Mentorship Program
      • Startup Project
    • Home
      • Summer and Winter Courses
      • Summer Courses
      • Online Courses
      • Workshop
      • Training
Public Health Update
  • Home
  • Public Health
    • Home 1
      • Adolescent Sexual and Reproductive Health (ASRH)
      • Antimicrobial Resistance (AMR)
      • Communicable Diseases
      • Digital Health & Health Informatics
      • Environmental Health & Climate Change
      • Health Financing and Economics
      • Health Equity
    • Home 2
      • Health Literacy, Health Education & Promotion
      • Human Resource for Health
      • Humanitarian Health & Emergency Response
      • Implementation Research
      • International Health
      • Life Style & Public Health Nutrition
      • Maternal, Newborn and Child Health
    • Home 3
      • Neglected Tropical Diseases (NTDs)
      • Non- Communicable Diseases (NCDs)
      • One Health
      • Planetary Health
      • Public Health Epidemiology & Biostatistics
      • Primary Health Care
      • Quality Improvement & Infection Prevention
    • Home 4
      • Road Traffic Accidents (RTA)
      • Sustainable Development Goals (SDGs)
      • Tobacco Control
      • Universal Health Coverage
      • Vaccine Preventable Diseases
      • Vector-Borne Diseases(VBDs)
      • Notices
  • Public Health Update
    • Home 1
      • Public Health News
      • Global Health News
      • Outbreak News
      • National Health News
      • COVID-19
    • Home 2
      • Fact Sheet
      • Health in Data
      • PH Important Day
      • Public Health Events
      • Public Health Programs
    • Home 3
      • Health Systems
      • Health Insurance
      • Health Organization Profile
      • Success Stories
      • Public Health Innovation
  • Public Health Opportunities
    • Fully funded
    • Travel Grants
    • Grants and Funding Opportunities
    • Opportunities by Region
    • International Jobs & Opportunities
    • Research & Project Grants
    • Fellowships, Studentship & Scholarships
    • Conference
  • Jobs
    • Home 1
      • Health Jobs
      • Public Health Jobs
      • Clinical doctor Jobs
      • Health Assistant Jobs
      • Nursing Jobs
      • PCL Health Science Jobs
    • Home 2
      • Dental Jobs
      • Pharmacist Jobs
      • TSLC (Health Jobs)
      • Laboratory Jobs
      • Nutritionist Jobs
  • Downloads
    • International Plan, Policy & Guidelines
    • National Plan, Policy & Guidelines
    • Reports
    • Books
    • Research Articles
  • School of Public Health
    • Home 1
      • Courses
      • Master’s Degree
      • Undergraduate Degree
      • PhD
    • Home 2
      • Universities
      • Syllabus
      • Public Health Notes
      • Mentorship Program
      • Startup Project
    • Home
      • Summer and Winter Courses
      • Summer Courses
      • Online Courses
      • Workshop
      • Training
Public Health Initiative, A Registered Non-profit organization – All Right Reserved. 2011-2023